EXELON
Identification of Exelon
| No description |
Google image searchProduct monograph
Active ingredient
rivastigmine (rivastigmine hydrogen tartrate), 1.5 MG
DIN: 02242115
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: KNIGHT THERAPEUTICS INC.
Date: 24-NOV-2022
ATC:
- N06 — PSYCHOANALEPTICS (ATC, ATC/DDD, )
- N06D — ANTI-DEMENTIA DRUGS (ATC, ATC/DDD)
- N06DA — Anticholinesterases (ATC, ATC/DDD)
- N06DA03 — RIVASTIGMINE (ATC/DDD)
Reference brand drug: Exelon
Pharmaceutical standard: MFR
